Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | APLT |
---|---|---|
09:32 ET | 15219 | 8.5 |
09:34 ET | 1224 | 8.38 |
09:36 ET | 1852 | 8.355 |
09:38 ET | 5370 | 8.34 |
09:39 ET | 1000 | 8.41 |
09:41 ET | 8947 | 8.39 |
09:43 ET | 204 | 8.39 |
09:45 ET | 5304 | 8.48 |
09:48 ET | 7616 | 8.51 |
09:50 ET | 2300 | 8.49 |
09:52 ET | 1700 | 8.45 |
09:54 ET | 3161 | 8.46 |
09:56 ET | 8287 | 8.53 |
09:57 ET | 2222 | 8.475 |
09:59 ET | 1029 | 8.5 |
10:01 ET | 3304 | 8.505 |
10:03 ET | 22661 | 8.54 |
10:06 ET | 621 | 8.515 |
10:08 ET | 3673 | 8.48 |
10:10 ET | 27754 | 8.45 |
10:12 ET | 2558 | 8.47 |
10:14 ET | 4070 | 8.45 |
10:15 ET | 100 | 8.43 |
10:17 ET | 4428 | 8.47 |
10:19 ET | 1000 | 8.42 |
10:21 ET | 1679 | 8.41 |
10:24 ET | 4479 | 8.43 |
10:26 ET | 3750 | 8.465 |
10:28 ET | 13795 | 8.4 |
10:30 ET | 1348 | 8.37 |
10:32 ET | 8777 | 8.36 |
10:33 ET | 500 | 8.37 |
10:35 ET | 1299 | 8.375 |
10:37 ET | 1846 | 8.36 |
10:39 ET | 6496 | 8.41 |
10:42 ET | 4200 | 8.4 |
10:44 ET | 276 | 8.39 |
10:46 ET | 6418 | 8.36 |
10:48 ET | 400 | 8.35 |
10:50 ET | 3495 | 8.4 |
10:51 ET | 2611 | 8.36 |
10:53 ET | 511 | 8.3418 |
10:55 ET | 1218 | 8.34 |
10:57 ET | 3590 | 8.31 |
11:00 ET | 4767 | 8.35 |
11:02 ET | 5238 | 8.36 |
11:04 ET | 18160 | 8.22 |
11:06 ET | 1384 | 8.26 |
11:08 ET | 1400 | 8.305 |
11:09 ET | 2034 | 8.3 |
11:11 ET | 2854 | 8.27 |
11:13 ET | 757 | 8.28 |
11:15 ET | 2965 | 8.28 |
11:18 ET | 950 | 8.26 |
11:20 ET | 10942 | 8.22 |
11:22 ET | 5908 | 8.21 |
11:24 ET | 4071 | 8.26 |
11:26 ET | 200 | 8.26 |
11:27 ET | 1685 | 8.22 |
11:29 ET | 2000 | 8.235 |
11:31 ET | 817 | 8.23 |
11:33 ET | 316 | 8.25 |
11:36 ET | 1100 | 8.25 |
11:38 ET | 1638 | 8.24 |
11:40 ET | 6716 | 8.21 |
11:42 ET | 9970 | 8.21 |
11:44 ET | 2828 | 8.32 |
11:45 ET | 1227 | 8.31 |
11:47 ET | 500 | 8.3165 |
11:49 ET | 725 | 8.31 |
11:51 ET | 1950 | 8.31 |
11:54 ET | 1141 | 8.335 |
12:00 ET | 772 | 8.35 |
12:02 ET | 2988 | 8.34 |
12:03 ET | 670 | 8.34 |
12:05 ET | 2200 | 8.39 |
12:07 ET | 4360 | 8.38 |
12:09 ET | 1886 | 8.36 |
12:12 ET | 850 | 8.34 |
12:14 ET | 100 | 8.33 |
12:16 ET | 2885 | 8.3 |
12:20 ET | 1682 | 8.33 |
12:21 ET | 883 | 8.35 |
12:23 ET | 2767 | 8.35 |
12:25 ET | 1887 | 8.33 |
12:27 ET | 300 | 8.32 |
12:30 ET | 300 | 8.33 |
12:32 ET | 710 | 8.33 |
12:34 ET | 1911 | 8.3424 |
12:36 ET | 400 | 8.339 |
12:38 ET | 850 | 8.37 |
12:39 ET | 200 | 8.365 |
12:43 ET | 1225 | 8.36 |
12:45 ET | 700 | 8.37 |
12:48 ET | 2119 | 8.36 |
12:50 ET | 200 | 8.355 |
12:52 ET | 1012 | 8.36 |
12:54 ET | 26637 | 8.45 |
12:56 ET | 3635 | 8.43 |
12:57 ET | 1204 | 8.39 |
12:59 ET | 1373 | 8.3836 |
01:01 ET | 1682 | 8.33 |
01:03 ET | 880 | 8.36 |
01:06 ET | 1895 | 8.38 |
01:08 ET | 543 | 8.38 |
01:10 ET | 1850 | 8.365 |
01:12 ET | 1538 | 8.4 |
01:15 ET | 482 | 8.3913 |
01:17 ET | 400 | 8.395 |
01:19 ET | 100 | 8.4 |
01:21 ET | 8393 | 8.42 |
01:24 ET | 19412 | 8.415 |
01:26 ET | 4248 | 8.44 |
01:28 ET | 500 | 8.45 |
01:30 ET | 1380 | 8.42 |
01:32 ET | 1121 | 8.42 |
01:33 ET | 4103 | 8.39 |
01:35 ET | 12049 | 8.39 |
01:37 ET | 13416 | 8.36 |
01:39 ET | 1868 | 8.33 |
01:42 ET | 1000 | 8.31 |
01:44 ET | 300 | 8.31 |
01:46 ET | 100 | 8.31 |
01:48 ET | 2000 | 8.33 |
01:50 ET | 100 | 8.33 |
01:51 ET | 200 | 8.335 |
01:53 ET | 1391 | 8.349 |
01:55 ET | 2684 | 8.34 |
02:00 ET | 528 | 8.335 |
02:02 ET | 1486 | 8.335 |
02:04 ET | 100 | 8.33 |
02:06 ET | 432 | 8.34 |
02:08 ET | 1466 | 8.32 |
02:09 ET | 2442 | 8.325 |
02:11 ET | 899 | 8.33 |
02:13 ET | 200 | 8.3205 |
02:15 ET | 888 | 8.33 |
02:18 ET | 100 | 8.33 |
02:20 ET | 3814 | 8.32 |
02:22 ET | 1000 | 8.29 |
02:24 ET | 1482 | 8.32 |
02:26 ET | 1820 | 8.27 |
02:27 ET | 952 | 8.27 |
02:29 ET | 100 | 8.27 |
02:31 ET | 6001 | 8.27 |
02:33 ET | 1750 | 8.2819 |
02:36 ET | 1100 | 8.28 |
02:38 ET | 2400 | 8.26 |
02:40 ET | 3778 | 8.255 |
02:42 ET | 900 | 8.27 |
02:44 ET | 200 | 8.27 |
02:45 ET | 645 | 8.27 |
02:47 ET | 2403 | 8.27 |
02:49 ET | 900 | 8.27 |
02:51 ET | 1400 | 8.3 |
02:54 ET | 1861 | 8.29 |
02:58 ET | 754 | 8.295 |
03:00 ET | 1045 | 8.3091 |
03:02 ET | 1100 | 8.29 |
03:03 ET | 2286 | 8.27 |
03:05 ET | 800 | 8.265 |
03:07 ET | 1702 | 8.27 |
03:09 ET | 300 | 8.28 |
03:12 ET | 10178 | 8.25 |
03:14 ET | 1300 | 8.23 |
03:16 ET | 1003 | 8.245 |
03:18 ET | 2013 | 8.221 |
03:20 ET | 1623 | 8.23 |
03:21 ET | 300 | 8.23 |
03:23 ET | 200 | 8.225 |
03:25 ET | 300 | 8.225 |
03:27 ET | 200 | 8.23 |
03:30 ET | 2767 | 8.24 |
03:32 ET | 1465 | 8.23 |
03:34 ET | 7563 | 8.25 |
03:36 ET | 3308 | 8.26 |
03:38 ET | 819 | 8.28 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Applied Therapeutics Inc | 965.9M | -5.5x | --- |
AnaptysBio Inc | 981.3M | -5.0x | --- |
IGM Biosciences Inc | 940.8M | -4.8x | --- |
Sana Biotechnology Inc | 949.9M | -3.8x | --- |
Autolus Therapeutics PLC | 926.0M | -3.1x | --- |
Cullinan Therapeutics Inc | 1.0B | -5.5x | --- |
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare metabolic diseases, including Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency, and PMM2-CDG. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy (DbCM) a fatal fibrosis of the heart. It has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type 2 diabetes, in which no drug-related adverse effects or tolerability issues were observed. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of Diabetic retinopathy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $965.9M |
---|---|
Revenue (TTM) | $-333.0K |
Shares Outstanding | 114.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.04 |
EPS | $-1.52 |
Book Value | $-0.20 |
P/E Ratio | -5.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.